SCHEMBL4421069

SCHEMBL4421069

CCCCCCCCCCCCCCCCOC(=O)C=Cc1ccc(OC)cc1

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
APP P05067 5/20 0.66
TDP1 Q9NUW8 2/20 0.65
GSK3B P49841 1/20 0.55
TAS1R3 Q7RTX0 1/20 0.54
TAS1R1 Q7RTX1 1/20 0.54
F3 P13726 1/20 0.54
ATM Q13315 2/20 0.53
THRB P10828 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HCAR2 Q8TDS4 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6674756 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL15611 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL8872489 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL4070148 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL8872231 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL4070152 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL59457 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL30746 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
SCHEMBL2489079 1.00 LMNA (0.68) LMNASMN1; SMN2APPTDP1GSK3B
Hydrochloric Acid SCHEMBL10437237 0.99 LMNA (0.70) LMNASMN1; SMN2APPTDP1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370657-B2 Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene CURNA, INC. (US) 2019-08-06 US disclosed
US-20170073680-A1 TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE CURNA, INC. 2017-03-16 US disclosed
EP-1187598-B1 MICROPIGMENT MIXTURE BASF SE (DE) 2009-10-21 EP disclosed